One day after the approval of this vaccine by the European Medicines Agency (EMA) – the third, after authorization for vaccines developed by Pfizer / BioNTech and Moderna -, the German executive reiterates his distrust, following the advice of his experts, who claim that “there is not enough data to make a statement about the effectiveness” of the vaccine in the elderly.
“We will now have to review the vaccine order” due to the “age limitations of the AstraZeneca vaccine”, said Minister Jens Spahn, who assured that he wanted to “apply” the recommendation issued by national experts, contrary to the EMA’s position, which authorized the introduction of the vaccine on the market without age restrictions over 18 years.
The official authorization from the German authorities is expected to be known early next week, as Chancellor Angela Merkel called a meeting with health officials on the matter for Monday.
Jens Spahn pointed out the administration of the vaccine developed by the University of Oxford and AstraZeneca preferentially to health professionals, at a time when, according to the Robert Koch Institute for Health Surveillance, 2.2% of the German population had received at least one dose of vaccine till Friday.
Despite the controversy surrounding delays in the delivery of vaccines, the German official said today that the country expected to receive “five million additional doses by February 22”, among the three vaccines already approved.
Germany recorded 12,321 new cases of covid-19 and 794 deaths in the last 24 hours, according to data from the Robert Koch Institute, which indicate that the main figures continue to fall in the most populous country in the European Union.
Since the beginning of the pandemic, the country has registered a total of 2,205,171 cases of infection by the SARS-CoV-2 virus and 56,546 deaths from covid-19.
The covid-19 pandemic caused at least 2,206,873 deaths resulting from more than 102 million cases of infection worldwide, according to a report made by the French agency AFP.